Presentation by Prof Chris Rowe, ADNet, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Stewart Ferguson, PhD
Acting CIO, Alaska Native Tribal Health Consortium and Director, Alaska Federal Health Care Access Network (AFHCAN)
John Kokesh, MD
Medical Director, Department of Otolaryngology, Alaska Native Medical Center
(4/11/10, Illott, 2.15)
In a world where medical software is systemically plagued by complexity, OMS is helping cardiologists take back control. Created by and for cardiologists, allow us to restore your faith in what's possible.
We are specializing in medical supplies, especially through research and development, production and export.
Supported by staff with the capacity to introduce top-of-the-line products and the passion for the well-being of people all over the world, we will continue to challenge ourselves to become the company, which gives value to society.
By basing all our activities on our business principles of competition in quality rather than quantity, original products rather than imitations, and creation of innovative products rather than extension of existing ones.
Stewart Ferguson, PhD
Acting CIO, Alaska Native Tribal Health Consortium and Director, Alaska Federal Health Care Access Network (AFHCAN)
John Kokesh, MD
Medical Director, Department of Otolaryngology, Alaska Native Medical Center
(4/11/10, Illott, 2.15)
In a world where medical software is systemically plagued by complexity, OMS is helping cardiologists take back control. Created by and for cardiologists, allow us to restore your faith in what's possible.
We are specializing in medical supplies, especially through research and development, production and export.
Supported by staff with the capacity to introduce top-of-the-line products and the passion for the well-being of people all over the world, we will continue to challenge ourselves to become the company, which gives value to society.
By basing all our activities on our business principles of competition in quality rather than quantity, original products rather than imitations, and creation of innovative products rather than extension of existing ones.
Cardiff University Healthy Ageing Conference & Public Lecture
The importance of a healthy lifestyle
A Conference and a Public Lecture
Thursday 30th October 2014
http://medicine.cardiff.ac.uk/event/healthy-ageing-conference-public-lecture/
What is a Brain CT Imaging Perfusion Study?Carestream
Computed tomography perfusion (aka CTP) imaging shows which areas of the brain are supplied or perfused adequately with blood and provides detailed information on delivery of blood or blood flow to the brain. Here are 10 things you need to know about the procedure.
Challenges and improvements in diagnostic services across seven day services NHS Improving Quality
Prof Erika Denton, National Clinical Director for Diagnostics. Slides from Erika's presentation at the 7 Day services events in West Midlands 11th June and East Midlands 12th June, 2014.
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...Oleg Kshivets
5-year survival of ECP after radical procedures significantly depended on: 1) PT “early-invasive cancer”; 2) PT N0--N12; 3) Cell Ratio Factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) EC cell dynamics; 9) EC characteristics; 10) tumor localization; 11) anthropometric data; 12) surgery type. Optimal diagnosis and treatment strategies for EC are: 1) screening and early detection of EC; 2) availability of experienced thoracoabdominal surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for ECP with unfavorable prognosis.
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...Joris van Dijk
Background: Myocardial perfusion imaging (MPI) using Rubidium-82 (Rb-82) PET is more accurate than using SPECT. However, downstream clinical treatment strategies have not been compared.
Purpose: Our aim was to compare MPI scan outcomes and post-scan referral for invasive coronary angiography (ICA) between patients undergoing MPI with cadmium-zinc -telluride (CZT)-SPECT or PET in perfectly comparable groups generated by propensity score matching.
Method: 1188 patients who underwent MPI CZT-SPECT (Discovery 570, GE Healthcare) with attenuation correction and 487 patients who underwent Rb-82 PET (D690, GE Healthcare) were retrospectively analyzed. Propensity score-based matching was performed using calcium score category (0, 1-100, 101-400, >400), gender, age, body weight, current smoker, diabetes mellitus, hypercholesterolemia, hypertension and family history as variables. The frequency of normal scans, post scan ICA, and percutaneous coronary intervention (PCI) or coronary bypass surgery (CABG) within six months, were compared between SPECT and PET patients.
Results: After matching, no significant differences were found between the PET (n=487) and SPECT group (n=487) except for weight (91 vs. 87kg, respectively, p<0.001). PET scans were more often interpreted as normal (84% vs. 74%, p<0.001). The number of scans showing ischemia or possible ischemia was lower for PET (10.8%) than for SPECT (21.2%, p<0.001). The percentage of ICA (9.7 vs. 11.3%, p=0.41), PCI (1.9% vs. 2.5%, p=0.51) or CABG (1.4% vs. 1.6%,p=0.80) did not differ between the PET and SPECT, respectively.
Conclusion: As compared to CZT-SPECT, Rb-82 PET MPI results in more normal scans and fewer diagnoses of ischemia and doubtful ischemia. However, this did not translate to fewer ICA and PCI procedures within 6 months, but this may require more experience among referring cardiologists.
(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...Scintica Instrumentation
About Rutgers Molecular Imaging Center and the Aspect M2
The Rutgers Molecular Imaging Center received the Aspect M2 in the summer of 2012. With the versatility of the M2, a wide range of studies and over 85000 scans have been completed at the center. We have had conventional scans such as cancers, traumatic brain injuries, contrast agents, and other biologicals. The center has also reviewed items such as flow measurements of toothpaste, water filters in action, and pills breaking down during digestion. Please join us as we review examples of the various scans completed here at Rutgers University.
The Rutgers Molecular Imaging Center received the Aspect M2 in 2012. Since the M2’s arrival, it has been one of the most utilized instruments at our center. As of May 1st, 2021, the instrument has seen over 6900 hours of use generating 450 projects/patient files comprising a total of over 85,000 scans. Since the M2 was installed, a combination of 60 departments (over 100 researchers) from multiple universities and pharmaceutical companies have had scans completed at Rutgers. At least ten users from five different departments have been trained over the years to independently run the MRI. This webinar will highlight some of the scans completed here at the center.
One major focus of the center has been the brain and central nervous system. Some examples are the following: Longevity scans of Traumatic Brain Injury have been completed using the Mouse Brain Coil. For another TBI investigator project, leakage into the ventricles post-injury has been tracked with the use of positive contrast agents. Negative contrast agents have been utilized to track stem cells traveling from the lower vertebrae up the spine to points of injury or accumulating around damage in the brain. Changes to the brain following low levels of radiation exposure have been observed using the rat coil. Spontaneous paralysis was reviewed when phenotyping a new mouse strain. A wound healing model tracked the progress of recovery within a spinal injury model.
A second important focus involves cancer models actively scanned at Rutgers. Multiple investigators track the progress of lung cancer and its metastasis. Another investigator tracked cancers in the liver through an interesting negative contrast technique. One Cancer Institute of NJ investigator tracked prostate growth in the same mice for up to two years. Yet another research group tracked an aggressive lymphoma on a weekly basis. Other interesting cancer scans that have been recorded are tumors in the bone, under the tongue, breast duct, uterus, just to name a few of the ones scanned at the center.
Presentation by Dr Steve McEachern, ADA, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Hugo Leroux and Liming Zhu, CSIRO, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Cardiff University Healthy Ageing Conference & Public Lecture
The importance of a healthy lifestyle
A Conference and a Public Lecture
Thursday 30th October 2014
http://medicine.cardiff.ac.uk/event/healthy-ageing-conference-public-lecture/
What is a Brain CT Imaging Perfusion Study?Carestream
Computed tomography perfusion (aka CTP) imaging shows which areas of the brain are supplied or perfused adequately with blood and provides detailed information on delivery of blood or blood flow to the brain. Here are 10 things you need to know about the procedure.
Challenges and improvements in diagnostic services across seven day services NHS Improving Quality
Prof Erika Denton, National Clinical Director for Diagnostics. Slides from Erika's presentation at the 7 Day services events in West Midlands 11th June and East Midlands 12th June, 2014.
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...Oleg Kshivets
5-year survival of ECP after radical procedures significantly depended on: 1) PT “early-invasive cancer”; 2) PT N0--N12; 3) Cell Ratio Factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) EC cell dynamics; 9) EC characteristics; 10) tumor localization; 11) anthropometric data; 12) surgery type. Optimal diagnosis and treatment strategies for EC are: 1) screening and early detection of EC; 2) availability of experienced thoracoabdominal surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for ECP with unfavorable prognosis.
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...Joris van Dijk
Background: Myocardial perfusion imaging (MPI) using Rubidium-82 (Rb-82) PET is more accurate than using SPECT. However, downstream clinical treatment strategies have not been compared.
Purpose: Our aim was to compare MPI scan outcomes and post-scan referral for invasive coronary angiography (ICA) between patients undergoing MPI with cadmium-zinc -telluride (CZT)-SPECT or PET in perfectly comparable groups generated by propensity score matching.
Method: 1188 patients who underwent MPI CZT-SPECT (Discovery 570, GE Healthcare) with attenuation correction and 487 patients who underwent Rb-82 PET (D690, GE Healthcare) were retrospectively analyzed. Propensity score-based matching was performed using calcium score category (0, 1-100, 101-400, >400), gender, age, body weight, current smoker, diabetes mellitus, hypercholesterolemia, hypertension and family history as variables. The frequency of normal scans, post scan ICA, and percutaneous coronary intervention (PCI) or coronary bypass surgery (CABG) within six months, were compared between SPECT and PET patients.
Results: After matching, no significant differences were found between the PET (n=487) and SPECT group (n=487) except for weight (91 vs. 87kg, respectively, p<0.001). PET scans were more often interpreted as normal (84% vs. 74%, p<0.001). The number of scans showing ischemia or possible ischemia was lower for PET (10.8%) than for SPECT (21.2%, p<0.001). The percentage of ICA (9.7 vs. 11.3%, p=0.41), PCI (1.9% vs. 2.5%, p=0.51) or CABG (1.4% vs. 1.6%,p=0.80) did not differ between the PET and SPECT, respectively.
Conclusion: As compared to CZT-SPECT, Rb-82 PET MPI results in more normal scans and fewer diagnoses of ischemia and doubtful ischemia. However, this did not translate to fewer ICA and PCI procedures within 6 months, but this may require more experience among referring cardiologists.
(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...Scintica Instrumentation
About Rutgers Molecular Imaging Center and the Aspect M2
The Rutgers Molecular Imaging Center received the Aspect M2 in the summer of 2012. With the versatility of the M2, a wide range of studies and over 85000 scans have been completed at the center. We have had conventional scans such as cancers, traumatic brain injuries, contrast agents, and other biologicals. The center has also reviewed items such as flow measurements of toothpaste, water filters in action, and pills breaking down during digestion. Please join us as we review examples of the various scans completed here at Rutgers University.
The Rutgers Molecular Imaging Center received the Aspect M2 in 2012. Since the M2’s arrival, it has been one of the most utilized instruments at our center. As of May 1st, 2021, the instrument has seen over 6900 hours of use generating 450 projects/patient files comprising a total of over 85,000 scans. Since the M2 was installed, a combination of 60 departments (over 100 researchers) from multiple universities and pharmaceutical companies have had scans completed at Rutgers. At least ten users from five different departments have been trained over the years to independently run the MRI. This webinar will highlight some of the scans completed here at the center.
One major focus of the center has been the brain and central nervous system. Some examples are the following: Longevity scans of Traumatic Brain Injury have been completed using the Mouse Brain Coil. For another TBI investigator project, leakage into the ventricles post-injury has been tracked with the use of positive contrast agents. Negative contrast agents have been utilized to track stem cells traveling from the lower vertebrae up the spine to points of injury or accumulating around damage in the brain. Changes to the brain following low levels of radiation exposure have been observed using the rat coil. Spontaneous paralysis was reviewed when phenotyping a new mouse strain. A wound healing model tracked the progress of recovery within a spinal injury model.
A second important focus involves cancer models actively scanned at Rutgers. Multiple investigators track the progress of lung cancer and its metastasis. Another investigator tracked cancers in the liver through an interesting negative contrast technique. One Cancer Institute of NJ investigator tracked prostate growth in the same mice for up to two years. Yet another research group tracked an aggressive lymphoma on a weekly basis. Other interesting cancer scans that have been recorded are tumors in the bone, under the tongue, breast duct, uterus, just to name a few of the ones scanned at the center.
Presentation by Dr Steve McEachern, ADA, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Hugo Leroux and Liming Zhu, CSIRO, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Kelly Hart, ONDC in PM&C, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Investigator-initiated clinical trials: a community perspectiveARDC
Presentation by Miranda Cumpston, ACTA, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Merran Smith, PHRN, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
International perspective for sharing publicly funded medical research dataARDC
Presentation by Olivier Salvado, CSIRO, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Prof Lisa Askie, ANZCTR, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Davina Ghersi, NHMRC, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
Presentation by Dr Adrian Burton, ARDC, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
FAIR for the future: embracing all things dataARDC
FAIR for the future: embracing all things data - Natasha Simons, Keith Russell and Liz Stokes, presented at Taylor & Francis Scholarly Summits in Sydney 11 Feb 2019 and Melbourne 14 Feb 2019.
How to make your data count webinar, 26 Nov 2018ARDC
Slides from the 26 Nov Make your data count webinar. The research community has long grappled with the problem of assessing and tracking the results of scholarship. Research data is no exception. The Make Data Count (MDC) project (https://makedatacount.org/), funded by the Sloan Foundation, has delivered a data usage metric standard (Code of Practice) and a workflow for the retrieval and display of standardised usage and citation metrics in your repository interface.
Listen to this webinar to learn more about the Make Data Count project and the 5 steps you can take to make the data in your repository count. Hear from MDC project team members who have already implemented MDC in the dash (https://dash.ucop.edu) and DataOne (https://search.dataone.org/data) repositories. Learn from their experience, see the results.
Our international speaker line-up includes Daniella Lowenberg (California Digital Library) and Patricia Cruse (DataCite).
Recording available: https://youtu.be/Lkysz0Mc7fo
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
3. ADNeT in a Nutshell
• Clinical Quality Registry (CQR) for newly diagnosed
dementia or “mild cognitive impairment”
• Memory Clinics – expand, standardize and support
• Clinical Trial sites – expand and support
• Longitudinal (n=4,000) and Trial ready (n=500) cohorts –
blood, MRI, cognition, amyloid and tau PET, +/- CSF every 2 years
4. ADNeT Tech
1.Provide IT infrastructure and support for the key ADNeT initiatives
2.Develop and harmonise innovative diagnostic technologies (i.e. PET
and MRI imaging and blood and CSF biomarkers).
7. 3,500 researchers granted access to AIBL data via
www.adni.loni.usc.edu
Includes access granted to 112 companies e.g.:
Abbott Labs, Abiant, ADM diagnostics, Astra Zeneca, Avid, BioClinica, Biogen Idec, Bristol-Myers Squibb, Cogstate Cytokinetics, Eisai, Elan, Eli Lilly, GE Health Care,
General Resonance, Genetech, Imorphics, Iris Biotechnologies, Janssen, Johnson Johnson, M and M Scientific, Merck & Co, Mimvista, Pentara Corp, Pfizer, Philips,
Predixion software, Rancho Biosciences, Servier, Siemens, Soft team solutions, UCB, United Biosource Corp.
AIBL has also received 250 Expressions of Interest for access to more detailed data.
Bangladesh
China
Hong Kong
India
Indonesia
Japan
Kyrgyzstan
Malaysia
Pakistan
Philippines
Singapore
South Korea
Taiwan
Thailand
Australia
New Zealand
Iran
Iraq
Israel
Saudi Arabia
Turkey
Canada
Cuba
Martinique
Mexico
Puerto Rico
USA
Argentina
Bolivia
Brazil
Chile
Colombia
Ecuador
Guyana
Netherlands Antilles
Peru
Uruguay
Austria
Belgium
Bulgaria
Cyprus
Denmark
Estonia
Finland
France
Algeria
Egypt
Ghana
Morocco
Nigeria
Tunisia
Germany
Greece
Hungary
Ireland
Italy
Lithuania
Luxembourg
Macedonia
Netherlands
Norway
Poland
Portugal
Romania
Russia
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Ukraine
UK